Research map: Microbiome-driven resistance in cervical cancer therapy: from mechanistic dissection to clinical translation
Back to the article
Papers in this map
The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance
· Yu He · 2026 · Cites this paper
Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer
· 2026 · Related
Lactylation and human disease
· 2025 · Related
The sphingolipid rheostat in female reproductive pathologies: from molecular mechanisms to precision therapeutics
· 2026 · Related
Genetic and Epigenetic Approaches to Opioid Use Disorder
· 2025 · Related
Harnessing the vaginal microbiome: a new frontier in the prevention of sexually transmitted infections
· 2026 · Related
Dysregulation of the urea cycle – potential targets for treatment and diagnosis in prostate cancer
· 2026 · Related
A Comprehensive Evaluation of CAR-T Cell Gene Therapy, Tracing its Revolutionary Clinical Breakthroughs and Advancements Towards Next-Generation Engineering
· 2026 · Related
Exosome Nanotechnology in Molecular Medicine: Advances, Applications and Challenges in Gene Therapy
· 2026 · Related
Current in vitro myocardial infarction co-culture models and their verification for clinical relevance
· 2026 · Related
Source: OpenAlex (CC0)